MACUSTAR: Development and Clinical Validation of Functional, Structural, and Patient-Reported Endpoints in Intermediate Age-Related Macular Degeneration

PURPOSE: Currently, no outcome measures are clinically validated and accepted as clinical endpoints by regulatory agencies for drug development in intermediate age-related macular degeneration (iAMD). The MACUSTAR Consortium, a public-private research group funded by the European Innovative Medicine...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ophthalmologica
Main Authors: Finger, Robert P., Schmitz-Valckenberg, Steffen, Schmid, Matthias, Rubin, Gary S., Dunbar, Hannah, Tufail, Adnan, Crabb, David P., Binns, Alison, Sánchez, Clara I., Margaron, Philippe, Normand, Guillaume, Durbin, Mary K., Luhmann, Ulrich F.O., Zamiri, Parisa, Cunha-Vaz, José, Asmus, Friedrich, Holz, Frank G.
Formato: Artigo
Idioma:Inglês
Publicado em: S. Karger AG 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6482983/
https://ncbi.nlm.nih.gov/pubmed/30153664
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000491402
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados